Tag: noncolorectal gastrointestinal cancer

Immunotherapy Likely New Standard in Advanced Esophageal Cancer

Nivolumab (Opdivo) plus chemotherapy and nivolumab plus ipilimumab (Yervoy) were superior to standard chemotherapy in improving overall survival in patients with advanced esophageal squamous cell...

Liver, Gastric Cancer Disparities Consistent Across Race

While colorectal cancer may be the most common and deadly gastrointestinal malignancy, liver and gastric cancers account for some of the most consistent racial and...

FDA Panel Votes Against Two Cancer Indications but Backs 4 of 6

Federal advisers this week supported the efforts of pharmaceutical companies in 4 of 6 cases in which these firms are fighting to maintain cancer indications...

Global Demand for Cancer Surgery Expected to Soar

Global demand for cancer surgery will increase by 52% by 2040, with underresourced, low-income countries shouldering the greatest burden, a modeling study suggests. A second...

Better Survival With S-1/Docetaxel in Stage III Gastric Cancer

A new recommendation for the treatment of patients with gastric cancer has been proposed on the basis of final results from the phase 3 trial...

Gut Microbiome Predicts Nivolumab Efficacy in Gastric Cancer?

Preliminary data suggest that a certain pattern of gut microbes may be useful in predicting which patients with advanced gastric cancer are likely to benefit...

Most Common Cancer Diagnosis Globally: Breast Surpasses Lung

Breast cancer now tops the list of the most commonly diagnosed cancers worldwide, surpassing lung cancer for the first time, according to the latest global...

Global Stomach Cancer Deaths Decline as CRC Deaths Stagnate, Rise

A global analysis of premature deaths from noncommunicable diseases (NCDs) has shown mixed results for gastrointestinal (GI) cancers. The data suggest fewer people are dying...

In a First, Proton Therapy Bests Radiotherapy in an RCT

In a first, proton beam therapy has demonstrated significantly reduced toxicity when compared with conventional radiotherapy in a randomized controlled trial (RCT) in patients with...

Garlic Supplements, H. Pylori Treatment Tied to Lower Gastric Cancer Mortality

(Reuters Health) – Treatment for Helicobacter pylori and garlic supplementation are each associated with lowered gastric cancer mortality risk, but garlic’s benefits are mainly in...

FDA Approves First Targeted Drug for Bile Duct Cancer

The US Food and Drug Administration (FDA) has granted accelerated approval of a new targeted therapy for use in some patients with cholangiocarcinoma, a rare cancer...

Differences in How Men and Women Respond to Radiotherapy?

Men and women who undergo treatment for cancer react differently to radiotherapy (RT), according to evidence drawn from a literature review. The study found a...